L-THP is a shortened label name for levo-tetrahydropalmatine, also written as L-tetrahydropalmatine. Tetrahydropalmatine is an alkaloid associated with several plant sources, and the “L” or “levo” wording identifies a particular stereochemical form. That naming detail matters: a short product title should still connect clearly to the ingredient named on the full panel.
For shoppers, the useful questions are straightforward. What exact ingredient is listed? How many milligrams are stated per tablet or serving? Is L-THP the only highlighted component or part of a combination? What supporting documentation is available? The label can answer those questions; it cannot guarantee a result.
Recognize the Name Variations
A listing may use “L-THP,” “levo-tetrahydropalmatine,” or “L-tetrahydropalmatine.” These terms are used to refer to the levo form. “Tetrahydropalmatine” without a stereochemical prefix can be less specific, so check the complete ingredient panel rather than relying on an abbreviated category title.
NIH PubChem provides chemical identity and synonym information for tetrahydropalmatine. Chemical databases are useful for names, structures, and identifiers. They do not establish that every retail product has the same purity, formulation, serving instructions, or evidence base.
Read the Strength Statement Carefully
Find the number, unit, and amount basis together. A listing should indicate whether the stated milligrams apply:
- to one tablet;
- to a serving containing multiple tablets;
- or to the full package.
For example, 40 mg per two-tablet serving equals 20 mg per tablet. That calculation only normalizes the label. It does not establish a recommended amount or predict an individual response. Follow the product directions and do not create a serving conversion from a different ingredient or category.
Single-Ingredient and Combination Labels
Single-ingredient presentation
When L-THP is the only named active component, confirm its amount, serving basis, tablet count, format, and other ingredients. “Single ingredient” describes the highlighted active panel; the tablet will still contain formulation ingredients such as binders or flavor components.
Combination presentation
If L-THP appears with other botanical extracts or alkaloid ingredients, record each disclosed amount separately. A large total on the front of the package may describe the full combination rather than the L-THP portion. When component amounts are not disclosed, they cannot be reconstructed from the total.
Evidence and Interaction Limits
Published L-THP literature includes laboratory, animal, and limited human research conducted for specific scientific questions. Findings from those settings should not be converted into broad claims about a commercial tablet. A chemical identity record also does not supply a standard consumer serving or prove a finished product’s performance.
Individual factors matter with concentrated botanical constituents. Anyone who uses prescription or over-the-counter medications, is pregnant or nursing, has a health condition, or has questions about combining ingredients should consult a qualified health professional. Avoid driving or operating machinery if a product warning or individual response indicates impairment.
Documentation Worth Checking
- Match the product and batch or lot identifier.
- Confirm whether the report identifies L-THP specifically or uses a broader name.
- Check the reported units and test method.
- Separate identity or constituent results from unrelated test categories.
- Compare the report date and batch with the item being sold.
Clear documentation improves traceability. It does not replace the full label, directions, warnings, or individual professional advice.
Compare Current L-THP Listings
Skip vague strength language and compare the disclosed fields. Browse current L-THP products at 7OH Factory, then check the complete ingredient name, amount basis, single or combination formula, tablet format, flavor, package count, and available documentation.
